Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
II
116TH CONGRESS 2D SESSION S. 3499
To amend coverage requirements to ensure that no person incurs cost sharing
when receiving a test to confirm a COVID–19 infection.
IN THE SENATE OF THE UNITED STATES
MARCH 12, 2020
Ms. SMITH (for herself, Mr. PETERS, Mr. SCHUMER, Mrs. MURRAY, Mr.
WYDEN, Mr. CASEY, Mr. JONES, Mr. BROWN, Ms. DUCKWORTH, Mr.
TESTER, Mr. WHITEHOUSE, Mr. SANDERS, Ms. BALDWIN, Mr. REED,
Mr. MURPHY, Ms. KLOBUCHAR, Ms. HIRONO, Mr. SCHATZ, Mr. KING,
Mr. COONS, Ms. STABENOW, Mr. BOOKER, Mrs. FEINSTEIN, Ms. HAR-
RIS, Mr. UDALL, Ms. HASSAN, Mrs. GILLIBRAND, Mr. HEINRICH, Ms.
ROSEN, Mrs. SHAHEEN, Mr. KAINE, Ms. WARREN, Mr. CARPER, Mr.
WARNER, Mr. VAN HOLLEN, Mr. DURBIN, Mr. MARKEY, Mr.
BLUMENTHAL, Mr. BENNET, and Mr. MENENDEZ) introduced the fol-
lowing bill; which was read twice and referred to the Committee on
Health, Education, Labor, and Pensions
A BILL To amend coverage requirements to ensure that no person
incurs cost sharing when receiving a test to confirm
a COVID–19 infection.
Be it enacted by the Senate and House of Representa-1
tives of the United States of America in Congress assembled, 2
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 3
(a) SHORT TITLE.—This Act may be cited as the 4
‘‘Free COVID–19 Testing Act’’. 5
VerDate Sep 11 2014 20:19 Mar 27, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
2
•S 3499 IS
(b) TABLE OF CONTENTS.—The table of contents of 1
this Act is as follows: 2
Sec. 1. Short title; table of contents.
Sec. 2. Coverage of testing for COVID–19.
Sec. 3. Waiving cost sharing under the Medicare program for certain visits re-
lating to testing for COVID–19.
Sec. 4. Coverage of testing for COVID–19 at no cost sharing under the Medi-
care Advantage program.
Sec. 5. Coverage at no cost sharing of COVID–19 testing under Medicaid and
CHIP.
Sec. 6. Laboratory reimbursement for diagnostic testing for COVID–19 in un-
insured individuals.
Sec. 7. Application with respect to TRICARE, coverage for veterans, and cov-
erage for Federal civilians.
Sec. 8. Coverage of testing for COVID–19 at no cost sharing for Indians re-
ceiving contract health services.
SEC. 2. COVERAGE OF TESTING FOR COVID–19. 3
(a) IN GENERAL.—A group health plan and a health 4
insurance issuer offering group or individual health insur-5
ance coverage (including a grandfathered health plan (as 6
defined in section 1251(e) of the Patient Protection and 7
Affordable Care Act)) shall provide coverage, and shall not 8
impose any cost sharing (including deductibles, copay-9
ments, and coinsurance) requirements or prior authoriza-10
tion or other medical management requirements, for the 11
following items and services furnished during any portion 12
of the emergency period defined in paragraph (1)(B) of 13
section 1135(g) of the Social Security Act (42 U.S.C. 14
1320b–5(g)) beginning on or after the date of the enact-15
ment of this Act: 16
(1) In vitro diagnostic products (as defined in 17
section 809.3(a) of title 21, Code of Federal Regula-18
tions) for the detection of SARS–CoV–2 or the diag-19
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
3
•S 3499 IS
nosis of the virus that causes COVID–19 that are 1
approved, cleared, or authorized under section 2
510(k), 513, 515, or 564 of the Federal Food, 3
Drug, and Cosmetic Act, and the administration of 4
such in vitro diagnostic products. 5
(2) Health care provider office visits, urgent 6
care center visits, and emergency room visits that 7
result in an order for or administration of an in 8
vitro diagnostic product described in paragraph (1). 9
(b) ENFORCEMENT.—The provisions of subsection 10
(a) shall be applied by the Secretary of Health and Human 11
Services, Secretary of Labor, and Secretary of the Treas-12
ury to group health plans and health insurance issuers of-13
fering group or individual health insurance coverage as if 14
included in the provisions of part A of title XXVII of the 15
Public Health Service Act, part 7 of the Employee Retire-16
ment Income Security Act of 1974, and subchapter B of 17
chapter 100 of the Internal Revenue Code of 1986, as ap-18
plicable. 19
(c) IMPLEMENTATION.—The Secretary of Health and 20
Human Services, Secretary of Labor, and Secretary of the 21
Treasury may implement the provisions of this section 22
through sub-regulatory guidance, program instruction, or 23
otherwise. 24
VerDate Sep 11 2014 00:00 Mar 27, 2020 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
4
•S 3499 IS
(d) TERMS.—The terms ‘‘group health plan’’, ‘‘health 1
insurance issuer’’, ‘‘group health insurance coverage’’, and 2
‘‘individual health insurance coverage’’ have the meanings 3
given such terms in section 2791 of the Public Health 4
Service Act (42 U.S.C. 300gg–91), section 733 of the Em-5
ployee Retirement Income Security Act of 1974 (29 6
U.S.C. 1191b), and section 9832 of the Internal Revenue 7
Code of 1986, as applicable. 8
SEC. 3. WAIVING COST SHARING UNDER THE MEDICARE 9
PROGRAM FOR CERTAIN VISITS RELATING 10
TO TESTING FOR COVID–19. 11
(a) IN GENERAL.—Section 1833 of the Social Secu-12
rity Act (42 U.S.C. 1395l) is amended— 13
(1) in subsection (a)(1)— 14
(A) by striking ‘‘and’’ before ‘‘(CC)’’; and 15
(B) by inserting before the period at the 16
end the following: ‘‘, and (DD) with respect to 17
a specified COVID–19 testing-related service 18
described in paragraph (1) of subsection (cc) 19
for which payment may be made under a speci-20
fied outpatient payment provision described in 21
paragraph (2) of such subsection, the amounts 22
paid shall be 100 percent of the payment 23
amount otherwise recognized under such respec-24
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
5
•S 3499 IS
tive specified outpatient payment provision for 1
such service,’’; 2
(2) in subsection (b), in the first sentence— 3
(A) by striking ‘‘and’’ before ‘‘(10)’’; and 4
(B) by inserting before the period at the 5
end the following: ‘‘, and (11) such deductible 6
shall not apply with respect to any specified 7
COVID–19 testing-related service described in 8
paragraph (1) of subsection (cc) for which pay-9
ment may be made under a specified outpatient 10
payment provision described in paragraph (2) 11
of such subsection’’; and 12
(3) by adding at the end the following new sub-13
section: 14
‘‘(cc) SPECIFIED COVID–19 TESTING-RELATED 15
SERVICES.—For purposes of subsection (a)(1)(DD): 16
‘‘(1) DESCRIPTION.— 17
‘‘(A) IN GENERAL.—A specified COVID– 18
19 testing-related service described in this para-19
graph is a medical visit that— 20
‘‘(i) is in any of the categories of 21
HCPCS evaluation and management serv-22
ice codes described in subparagraph (B); 23
‘‘(ii) is furnished during any portion 24
of the emergency period (as defined in sec-25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
6
•S 3499 IS
tion 1135(g)(1)(B)) beginning on or after 1
the date of the enactment of this sub-2
section; and 3
‘‘(iii) results in an order for or admin-4
istration of a diagnostic test described in 5
section 1852(a)(1)(B)(iv)(IV). 6
‘‘(B) CATEGORIES OF HCPCS CODES.—For 7
purposes of subparagraph (A), the categories of 8
HCPCS evaluation and management services 9
codes are the following: 10
‘‘(i) Office and other outpatient serv-11
ices. 12
‘‘(ii) Hospital observation services. 13
‘‘(iii) Emergency department services. 14
‘‘(iv) Nursing facility services. 15
‘‘(v) Domiciliary, rest home, or custo-16
dial care services. 17
‘‘(vi) Home services. 18
‘‘(2) SPECIFIED OUTPATIENT PAYMENT PROVI-19
SION.—A specified outpatient payment provision de-20
scribed in this paragraph is any of the following: 21
‘‘(A) The hospital outpatient prospective 22
payment system under subsection (t). 23
‘‘(B) The physician fee schedule under sec-24
tion 1848. 25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
7
•S 3499 IS
‘‘(C) The prospective payment system de-1
veloped under section 1834(o). 2
‘‘(D) Section 1834(g), with respect to an 3
outpatient critical access hospital service. 4
‘‘(E) The payment basis determined in 5
regulations pursuant to section 1833(a)(3) for 6
rural health clinic services.’’. 7
(b) CLAIMS MODIFIER.—The Secretary of Health 8
and Human Services shall provide for an appropriate 9
modifier (or other identifier) to include on claims to iden-10
tify, for purposes of subparagraph (DD) of section 11
1833(a)(1), as added by subsection (a), specified COVID– 12
19 testing-related services described in paragraph (1) of 13
section 1833(cc) of the Social Security Act, as added by 14
subsection (a), for which payment may be made under a 15
specified outpatient payment provision described in para-16
graph (2) of such subsection. 17
(c) IMPLEMENTATION.—Notwithstanding any other 18
provision of law, the Secretary of Health and Human 19
Services may implement the provisions of, including 20
amendments made by, this section through program in-21
struction or otherwise. 22
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
8
•S 3499 IS
SEC. 4. COVERAGE OF TESTING FOR COVID–19 AT NO COST 1
SHARING UNDER THE MEDICARE ADVAN-2
TAGE PROGRAM. 3
(a) IN GENERAL.—Section 1852(a)(1)(B) of the So-4
cial Security Act (42 U.S.C. 1395w–22(a)(1)(B)) is 5
amended— 6
(1) in clause (iv)— 7
(A) by redesignating subclause (IV) as 8
subclause (VI); and 9
(B) by inserting after subclause (III) the 10
following new subclauses: 11
‘‘(IV) Clinical diagnostic labora-12
tory test administered during any por-13
tion of the emergency period defined 14
in paragraph (1)(B) of section 15
1135(g) beginning on or after the 16
date of the enactment of the Free 17
COVID–19 Testing Act for the detec-18
tion of SARS–CoV–2 or the diagnosis 19
of the virus that causes COVID–19 20
and the administration of such test. 21
‘‘(V) Specified COVID–19 test-22
ing-related services (as described in 23
section 1833(cc)(1)) for which pay-24
ment would be payable under a speci-25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
9
•S 3499 IS
fied outpatient payment provision de-1
scribed in section 1833(cc)(2).’’; 2
(2) in clause (v), by inserting ‘‘, other than sub-3
clauses (IV) and (V) of such clause,’’ after ‘‘clause 4
(iv)’’; and 5
(3) by adding at the end the following new 6
clause: 7
‘‘(vi) PROHIBITION OF APPLICATION 8
OF CERTAIN REQUIREMENTS FOR COVID–19 9
TESTING.—In the case of a product or 10
service described in subclause (IV) or (V), 11
respectively, of clause (iv) that is adminis-12
tered or furnished during any portion of 13
the emergency period described in such 14
subclause beginning on or after the date of 15
the enactment of this clause, an MA plan 16
may not impose any prior authorization or 17
other utilization management requirements 18
with respect to the coverage of such a 19
product or service under such plan.’’. 20
(b) IMPLEMENTATION.—Notwithstanding any other 21
provision of law, the Secretary of Health and Human 22
Services may implement the amendments made by this 23
section by program instruction or otherwise. 24
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
10
•S 3499 IS
SEC. 5. COVERAGE AT NO COST SHARING OF COVID–19 1
TESTING UNDER MEDICAID AND CHIP. 2
(a) MEDICAID.— 3
(1) IN GENERAL.—Section 1905(a)(3) of the 4
Social Security Act (42 U.S.C. 1396d(a)(3)) is 5
amended— 6
(A) by striking ‘‘other laboratory’’ and in-7
serting ‘‘(A) other laboratory’’; 8
(B) by inserting ‘‘and’’ after the semicolon; 9
and 10
(C) by adding at the end the following new 11
subparagraph: 12
‘‘(B) in vitro diagnostic products (as defined in 13
section 809.3(a) of title 21, Code of Federal Regula-14
tions) administered during any portion of the emer-15
gency period defined in paragraph (1)(B) of section 16
1135(g) beginning on or after the date of the enact-17
ment of this subparagraph for the detection of 18
SARS–CoV–2 or the diagnosis of the virus that 19
causes COVID–19 that are approved, cleared, or au-20
thorized under section 510(k), 513, 515, or 564 of 21
the Federal Food, Drug, and Cosmetic Act, and the 22
administration of such in vitro diagnostic products;’’. 23
(2) NO COST SHARING.— 24
VerDate Sep 11 2014 00:00 Mar 27, 2020 Jkt 099200 PO 00000 Frm 00010 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
11
•S 3499 IS
(A) IN GENERAL.—Subsections (a)(2) and 1
(b)(2) of section 1916 of the Social Security 2
Act (42 U.S.C. 1396o) are each amended— 3
(i) in subparagraph (D), by striking 4
‘‘or’’ at the end; 5
(ii) in subparagraph (E), by striking 6
‘‘; and’’ and inserting a comma; and 7
(iii) by adding at the end the fol-8
lowing new subparagraphs: 9
‘‘(F) any in vitro diagnostic product de-10
scribed in section 1905(a)(3)(B) that is admin-11
istered during any portion of the emergency pe-12
riod described in such section beginning on or 13
after the date of the enactment of this subpara-14
graph (and the administration of such product), 15
or 16
‘‘(G) any medical visit for which payment 17
may be made under the State plan, that is fur-18
nished during any such portion of such emer-19
gency period, and that relates to testing for 20
COVID–19; and’’. 21
(B) APPLICATION TO ALTERNATIVE COST 22
SHARING.—Section 1916A(b)(3)(B) of the So-23
cial Security Act (42 U.S.C. 1396o–1(b)(3)(B)) 24
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00011 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
12
•S 3499 IS
is amended by adding at the end the following 1
new clause: 2
‘‘(xi) Any in vitro diagnostic product 3
described in section 1905(a)(3)(B) that is 4
administered during any portion of the 5
emergency period described in such section 6
beginning on or after the date of the enact-7
ment of this clause (and the administration 8
of such product) and any visit described in 9
section 1916(a)(2)(G) that is furnished 10
during any such portion.’’. 11
(C) CLARIFICATION.—The amendments 12
made this paragraph shall apply with respect to 13
a State plan of a territory in the same manner 14
as a State plan of one of the 50 States. 15
(3) STATE OPTION TO PROVIDE COVERAGE FOR 16
UNINSURED INDIVIDUALS.— 17
(A) IN GENERAL.—Section 1902(a)(10) of 18
the Social Security Act (42 U.S.C. 19
1396a(a)(10)) is amended— 20
(i) in subparagraph (A)(ii)— 21
(I) in subclause (XXI), by strik-22
ing ‘‘or’’ at the end; 23
(II) in subclause (XXII), by add-24
ing ‘‘or’’ at the end; and 25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00012 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
13
•S 3499 IS
(III) by adding at the end the 1
following new subclause: 2
‘‘(XXIII) during any portion of 3
the emergency period defined in para-4
graph (1)(B) of section 1135(g) be-5
ginning on or after the date of the en-6
actment of this subclause, who are un-7
insured individuals (as defined in sub-8
section (ss));’’; and 9
(ii) in the matter following subpara-10
graph (G)— 11
(I) by striking ‘‘and (XVII)’’ and 12
inserting ‘‘, (XVII)’’; and 13
(II) by inserting after ‘‘instead of 14
through subclause (VIII)’’ the fol-15
lowing: ‘‘, and (XVIII) the medical as-16
sistance made available to an unin-17
sured individual (as defined in sub-18
section (ss)) who is eligible for med-19
ical assistance only because of sub-20
paragraph (A)(ii)(XXIII) shall be lim-21
ited to medical assistance for any in 22
vitro diagnostic product described in 23
section 1905(a)(3)(B) that is adminis-24
tered during any portion of the emer-25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00013 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
14
•S 3499 IS
gency period described in such section 1
beginning on or after the date of the 2
enactment of this subclause (and the 3
administration of such product) and 4
any visit described in section 5
1916(a)(2)(G) that is furnished dur-6
ing any such portion’’. 7
(B) RECEIPT AND INITIAL PROCESSING OF 8
APPLICATIONS AT CERTAIN LOCATIONS.—Sec-9
tion 1902(a)(55) of the Social Security Act (42 10
U.S.C. 1396a(a)(55)) is amended, in the matter 11
preceding subparagraph (A), by striking ‘‘or 12
(a)(10)(A)(ii)(IX)’’ and inserting 13
‘‘(a)(10)(A)(ii)(IX), or (a)(10)(A)(ii)(XXIII)’’. 14
(C) UNINSURED INDIVIDUAL DEFINED.— 15
Section 1902 of the Social Security Act (42 16
U.S.C. 1396a) is amended by adding at the end 17
the following new subsection: 18
‘‘(ss) UNINSURED INDIVIDUAL DEFINED.—For pur-19
poses of this section, the term ‘uninsured individual’ 20
means, notwithstanding any other provision of this title, 21
any individual who is— 22
‘‘(1) not described in subsection (a)(10)(A)(i); 23
and 24
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00014 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
15
•S 3499 IS
‘‘(2) not enrolled in a Federal health care pro-1
gram (as defined in section 1128B(f)), a group 2
health plan, group or individual health insurance 3
coverage offered by a health insurance issuer (as 4
such terms are defined in section 2791 of the Public 5
Health Service Act), or a health plan offered under 6
chapter 89 of title 5, United States Code.’’. 7
(D) FEDERAL MEDICAL ASSISTANCE PER-8
CENTAGE.—Section 1905(b) of the Social Secu-9
rity Act (42 U.S.C. 1396d(b)) is amended by 10
adding at the end the following new sentence: 11
‘‘Notwithstanding the first sentence of this sub-12
section, the Federal medical assistance percent-13
age shall be 100 per centum with respect to 14
(and, notwithstanding any other provision of 15
this title, available for) medical assistance pro-16
vided to uninsured individuals (as defined in 17
section 1902(ss)) who are eligible for such as-18
sistance only on the basis of section 19
1902(a)(10)(A)(ii)(XXIII) and with respect to 20
expenditures described in section 1903(a)(7) 21
that a State demonstrates to the satisfaction of 22
the Secretary are attributable to administrative 23
costs related to providing for such medical as-24
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00015 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
16
•S 3499 IS
sistance to such individuals under the State 1
plan.’’. 2
(b) CHIP.— 3
(1) IN GENERAL.—Section 2103(c) of the So-4
cial Security Act (42 U.S.C. 1397cc(c)) is amended 5
by adding at the end the following paragraph: 6
‘‘(9) CERTAIN IN VITRO DIAGNOSTIC PRODUCTS 7
FOR COVID–19 TESTING.—The child health assist-8
ance provided to a targeted low-income child shall 9
include coverage of any in vitro diagnostic product 10
described in section 1905(a)(3)(B) that is adminis-11
tered during any portion of the emergency period de-12
scribed in such section beginning on or after the 13
date of the enactment of this subparagraph (and the 14
administration of such product).’’. 15
(2) COVERAGE FOR TARGETED LOW-INCOME 16
PREGNANT WOMEN.—Section 2112(b)(4) of the So-17
cial Security Act (42 U.S.C. 1397ll(b)(4)) is amend-18
ed by inserting ‘‘under section 2103(c)’’ after ‘‘same 19
requirements’’. 20
(3) PROHIBITION OF COST SHARING.—Section 21
2103(e)(2) of the Social Security Act (42 U.S.C. 22
1397cc(e)(2)) is amended— 23
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00016 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
17
•S 3499 IS
(A) in the paragraph header, by inserting 1
‘‘, COVID–19 TESTING,’’ before ‘‘OR PREGNANCY- 2
RELATED ASSISTANCE’’; and 3
(B) by striking ‘‘category of services de-4
scribed in subsection (c)(1)(D) or’’ and insert-5
ing ‘‘categories of services described in sub-6
section (c)(1)(D), in vitro diagnostic products 7
described in subsection (c)(9) (and administra-8
tion of such products), visits described in sec-9
tion 1916(a)(2)(G), or’’. 10
SEC. 6. LABORATORY REIMBURSEMENT FOR DIAGNOSTIC 11
TESTING FOR COVID–19 IN UNINSURED INDI-12
VIDUALS. 13
(a) REIMBURSEMENT.—Through the National Dis-14
aster Medical System under section 2812 of the Public 15
Health Service Act (42 U.S.C. 300hh–11), and in coordi-16
nation with the Administrator of the Centers for Medicare 17
& Medicaid Services, the Secretary of Health and Human 18
Services shall, subject to the availability of appropriations 19
under subsection (c), pay the claims of laboratories for 20
reimbursement, as described in subsection (a)(3)(D) of 21
such section 2812, for health services consisting of diag-22
nostic testing to detect or diagnose COVID–19 in unin-23
sured individuals. The amount that will be paid shall be 24
equal to the amount that would have been paid to a physi-25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00017 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
18
•S 3499 IS
cian or laboratory under Clinical Laboratory Fee Schedule 1
under section 1833(h)(8) of the Social Security Act. 2
(b) DEFINITION.—In this section, the term ‘‘unin-3
sured individual’’ means an individual who is not enrolled 4
in— 5
(1) a Federal health care program (as defined 6
under section 1128B(f) of the Social Security Act 7
(42 U.S.C. 1320a–7b(f))); or 8
(2) a group health plan or health insurance cov-9
erage offered by a health insurance issuer in the 10
group or individual market (as such terms are de-11
fined in section 2791 of the Public Health Service 12
Act (42 U.S.C. 300gg–91)) or a health plan offered 13
under chapter 89 of title 5, United States Code. 14
(c) FUNDING.—To carry out this section, there is au-15
thorized to be appropriated, and there is hereby appro-16
priated, out of amounts in the Treasury not otherwise obli-17
gated, $1,000,000,000, to remain available until ex-18
pended. 19
SEC. 7. APPLICATION WITH RESPECT TO TRICARE, COV-20
ERAGE FOR VETERANS, AND COVERAGE FOR 21
FEDERAL CIVILIANS. 22
(a) TRICARE.—The Secretary of Defense may not 23
require any copayment or other cost sharing under chap-24
ter 55 of title 10, United States Code, for in vitro diag-25
VerDate Sep 11 2014 00:00 Mar 27, 2020 Jkt 099200 PO 00000 Frm 00018 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
19
•S 3499 IS
nostic products described in paragraph (1) of section 2(a) 1
(or the administration of such products) or visits described 2
in paragraph (2) of such section furnished during any por-3
tion of the emergency period defined in paragraph (1)(B) 4
of section 1135(g) of the Social Security Act (42 U.S.C. 5
1320b–5(g)) beginning on or after the date of the enact-6
ment of this Act. 7
(b) VETERANS.—The Secretary of Veterans Affairs 8
may not require any copayment or other cost sharing 9
under chapter 17 of title 38, United States Code, for in 10
vitro diagnostic products described in paragraph (1) of 11
section 2(a) (or the adminsitration of such products) or 12
visits described in paragraph (2) of such section furnished 13
during any portion of the emergency period defined in 14
paragraph (1)(B) of section 1135(g) of the Social Security 15
Act (42 U.S.C. 1320b–5(g)) beginning on or after the date 16
of the enactment of this Act. 17
(c) FEDERAL CIVILIANS.—No copayment or other 18
cost sharing may be required for any individual occupying 19
a position in the civil service (as that term is defined in 20
section 2101(1) of title 5, United States Code) enrolled 21
in a health benefits plan, including any plan under chapter 22
89 of title 5, United States Code, or for any other indi-23
vidual currently enrolled in any plan under chapter 89 of 24
title 5 for diagnostic tests’’ after ‘‘including any plan 25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00019 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
20
•S 3499 IS
under chapter 89 of title 5, United States Code), for in 1
vitro diagnostic products described in paragraph (1) of 2
section 2(a) (or the administration of such products) or 3
visits described in paragraph (2) of such section furnished 4
during any portion of the emergency period defined in 5
paragraph (1)(B) of section 1135(g) of the Social Security 6
Act (42 U.S.C. 1320b–5(g)) beginning on or after the date 7
of the enactment of this Act. 8
SEC. 8. COVERAGE OF TESTING FOR COVID–19 AT NO COST 9
SHARING FOR INDIANS RECEIVING CON-10
TRACT HEALTH SERVICES. 11
The Secretary of Health and Human Services shall 12
cover, without the imposition of any cost sharing require-13
ments, the cost of providing any COVID–19 related items 14
and services as described in paragraph (1) of section 2(a) 15
(or the administration of such products) or visits described 16
in paragraph (2) of such section furnished during any por-17
tion of the emergency period defined in paragraph (1)(B) 18
of section 1135(g) of the Social Security Act (42 U.S.C. 19
320b–5(g)) beginning on or after the date of the enact-20
ment of this Act to Indians (as defined in section 4 of 21
the Indian Health Care Improvement Act (25 U.S.C. 22
1603)) receiving health services through the Indian Health 23
Service, regardless of whether such items or services have 24
been authorized under the contract health services system 25
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00020 Fmt 6652 Sfmt 6201 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS
21
•S 3499 IS
funded by the Indian Health Service or is covered as a 1
health service of the Indian Health Service. 2
Æ
VerDate Sep 11 2014 03:03 Mar 23, 2020 Jkt 099200 PO 00000 Frm 00021 Fmt 6652 Sfmt 6301 E:\BILLS\S3499.IS S3499kham
mon
d on
DS
KJM
1Z7X
2PR
OD
with
BIL
LS